!! *Stock price forecasts are predicted by Deep Learning processes by technical analysis, shouldn't been used for investment decision. This means that this stock is suited as a new addition to your portfolio as trading bullish markets is always a lot easier.ġ year Codex Acquisitions price prediction Codex Acquisitions Price prediction day by day Calendar date This means that if you invested $100 now, your current investment may be worth 6917.934$ on 2024 November 20, Wednesday. These predictions take several variables into account such as volume changes, price changes, market cycles, similar stocks.įuture price of the stock is predicted at 3.804863907481$ ( 6817.934% ) after a year according to our prediction system. Our site uses a custom algorithm based on Deep Learning that helps our users to decide if CODX could be a good portfolio addition. stock forecastĪs of 2023 November 20, Monday current price of CODX stock is 0.0550$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).Ĭodex Acquisitions stock price has been showing a declining tendency so we believe that similar market segments were not very popular in the given period. Contact ETF Channel Meet Our Editorial Staff.1 year Codex Acquisitions Forecast: 3.804863907481 *ĥ year Codex Acquisitions Forecast: 26.882 * About the Co-Diagnostics, Inc. Minutes ETF data powered by Ticker Technologies, and Mergent. Video widget and ETF videos powered by Market News Video. By visiting, using or viewing this site, youĪgree to the following Full Disclaimer & Terms of UseĪnd Privacy Policy. Liable for any loss or damage caused by your reliance on information obtained. its subsidiaries, partners, officers, employees, affiliates, or agents be held NASDAQ:CODX Co-Diagnostics (CODX) Stock Forecast & Price Target 1.33 +0.23 (+20.91) (As of ET) Compare Todays Range 1.10 1.36 50-Day Range 1.00 1.34 52-Week Range 0.98 3. All viewers agree that under noĬircumstances will BNK Invest, Inc. Transaction, or investment strategy is suitable for any specific person. None of the information contained herein constitutes a recommendation that any particular security, portfolio, or any of its affiliates, subsidiaries or partners. Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counselįrom, or recommendations by BNK Invest Inc. Get the latest Zacks research report on SELB - FREEįind the right mix of model portfolios today at ĭividendRank'ed Dow Transports ComponentsĮnergy Stocks You Can Buy Cheaper Than Insiders DidĬrossing Above Their 200 Day Moving AverageĬrossing Below Their 200 Day Moving AverageĬopyright © 2009 - 2023, All Rights Reserved Get the latest Zacks research report on ALTO - FREE Get the latest Zacks research report on CODX - FREE The average analyst target price data upon which this article was based, is courtesy of data provided by Zacks Investment Research via. These are questions that require further investor research. Below is a twelve month price history chart comparing the stock performance of CODX, ALTO, and SELB:īelow is a summary table of the current analyst target prices discussed above:įirst Trust Dow Jones Select MicroCap Index Fund ETFĪre analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Do the analysts have a valid justification for their targets, or are they behind the curve on recent company and industry developments? A high price target relative to a stock's trading price can reflect optimism about the future, but can also be a precursor to target price downgrades if the targets were a relic of the past. Similarly, ALTO has 230.58% upside from the recent share price of $4.84 if the average analyst target price of $16.00/share is reached, and analysts on average are expecting SELB to reach a target price of $5.50/share, which is 161.90% above the recent price of $2.10. Although CODX has traded at a recent price of $3.65/share, the average analyst target is 292.68% higher at $14.33/share. Three of FDM's underlying holdings with notable upside to their analyst target prices are Co-Diagnostics Inc (CODX), Alto Ingredients Inc (ALTO), and Selecta Biosciences Inc (SELB). With FDM trading at a recent price near $59.31 per unit, that means that analysts see 24.47% upside for this ETF looking through to the average analyst targets of the underlying holdings. 10 ETFs With Most Upside To Analyst Targets »
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |